Dr. Han Yeongmin is a neurosurgeon (MD, PhD). He is Medical Director and Director of the Neurosurgery Center at Incheon St. Mary’s Hospital. He treats cerebrovascular disease and peripheral nerve disorders. He also specializes in brain tumors and skull base surgery. Conditions include stroke, cerebral hemorrhage, cerebral infarction, and moyamoya disease. He performs PEN, PNP, and SNB. He also offers microscopic and endoscopic discectomy, artificial disc replacement, MIS-TLIF/minimally invasive spinal fusion, and vertebroplasty.
He earned his MD and PhD from The Catholic University of Korea. He served as a visiting professor in cerebrovascular and skull base surgery at Barrow Neurological Institute (Phoenix, Arizona, USA). He also served at Harborview Medical Center, University of Washington (Seattle, USA).
His publications include co-authorship of Chapter 52 of the Textbook of Korean Cerebrovascular Surgery. He also co-authored Acoustic Neuroma Oncology. He is a full member of KNS, KSCVS, KSBS, KBTS, KNTS, KSNS, and KSPNS.
Dr. Yang Se Yeon is a neurosurgeon and Head of the Department of Neurosurgery at Naeun Hospital. He specializes in cerebral infarction, cerebral hemorrhage, cerebral aneurysm, moyamoya disease, carotid artery stenosis, vascular dizziness, and head trauma.
He graduated from The Catholic University of Korea College of Medicine. He also earned a Master’s in Medicine there. He completed an internship and a neurosurgery residency at Catholic Medical Center. He then completed a clinical fellowship and served as a clinical assistant professor at Uijeongbu St. Mary’s Hospital.
He has served as a staff neurosurgeon at the Northern Gyeonggi Regional Trauma Center. He was also Head of Neurosurgery at G-SAM Hospital.
Surgical revascularisation is the primary treatment for Moyamoya disease in South Korea. Surgeons perform direct or indirect bypass procedures to restore blood flow to the brain. This intervention helps prevent strokes. It manages symptoms like transient ischaemic attacks in both children and adults.
Bookimed Expert Insight: South Korea holds the third-highest global rank in our database for specialised requests. This volume reflects the high domestic prevalence of the disease. Consequently, centres like Severance Hospital maintain massive patient volumes, treating 1.6 million outpatients annually. This deep clinical experience often leads to more refined surgical techniques for complex cerebrovascular cases.
Patient Consensus: Patients emphasise that surgery aims to prevent strokes rather than provide a total cure. Many report returning to normal life within a year after bypass surgery in South Korea.
Moyamoya disease surgery in South Korea is highly successful. Leading centres report over 80% good outcomes. They achieve 99.3% five-year survival for children and 92.9% for adults. Surgeons use revascularisation techniques. These procedures effectively reduce future stroke risks and stabilise neurological health.
Bookimed Expert Insight: South Korea is a global hub for Moyamoya. This is because the condition is more common there. Specialists like Dr Han Yeongmin at NAEUN Hospital have extensive training from top American institutes. Hospitals like Gangnam Severance were first in Asia to use robotic systems. This high case volume means Korean teams have refined bypass techniques. They achieve a level rarely seen in Australia.
Patient Consensus: Patients note that recovery can take months as brain perfusion improves. Most report that the first weeks are exhausting. However, they eventually return to normal activities like riding bikes and using both hands.
South Korean surgeons treat Moyamoya disease with revascularisation surgery. Techniques include direct STA-MCA bypass, indirect bypass, or combined methods. These procedures redirect blood to the brain. Major centres in Seoul and Incheon use JCI-accredited protocols. They perform thousands of neurosurgical operations annually.
Bookimed Expert Insight: South Korea is a global hub for Moyamoya because their specialists manage massive patient volumes. Dr Han Yeongmin at NAEUN HOSPITAL treats thousands of complex neurovascular cases yearly. Teams at Severance Hospital also manage high case volumes. This high volume means surgeons are experts at switching techniques mid-surgery. If vessel walls are too fragile for sutures, they shift from a direct to an indirect bypass.
Patient Consensus: Patients note that surgery aims to lower stroke risk rather than cure the condition. Many return to normal life within one year. They recommend confirming whether the surgeon prefers direct or combined techniques before travelling to Seoul.
Moyamoya surgery in South Korea is recommended promptly after diagnosis for symptomatic patients to prevent strokes. Specialist centres prioritise early intervention for children to avoid permanent neurological damage. Doctors advise surgery when imaging shows restricted blood flow. They also advise it if patients experience transient ischaemic attacks.
Bookimed Expert Insight: South Korea is a global hub for neurosurgery. Gangnam Severance Hospital performs 1,300 neurological operations annually. Experienced specialists like Dr Han Yeongmin at NAEUN Hospital often treat complex cerebrovascular cases. Patients should allow at least 14 days in South Korea. This covers pre-op scans, surgery, and a mandatory 7-day recovery period before flying.
Patient Consensus: Patients note that Moyamoya surgery is a time-sensitive decision rather than an elective one. Most recommend booking appointments at least 1 month in advance. This is because popular Seoul clinics often have significant waiting lists for specialist consultations.
South Korean hospitals provide specialised Moyamoya disease treatment for both children and adults. Specialised centres use revascularisation surgery to restore brain blood flow. Leading facilities such as Severance Hospital maintain high safety standards with JCI and KOIHA accreditations.
Bookimed Expert Insight: While adult cases are common, paediatric Moyamoya care in South Korea is exceptionally robust. Severance Hospital collaborates directly with the Children's Hospital of Philadelphia. This partnership gives paediatric patients international-standard protocols for complex revascularisation cases.
Patient Consensus: Patients note that recovery is a gradual process as new blood-flow pathways develop over several months. Many emphasise that South Korean hospitals require new diagnostic testing on-site. The surgical plan is confirmed only after this testing.
To manage symptoms and prevent strokes, Korean specialists prescribe cilostazol, aspirin, and clopidogrel. These drugs are supplementary. Surgical revascularisation remains the primary treatment. Specialists at JCI-accredited centres like Severance Hospital personalise prescriptions. They adjust them according to age and stroke risk.
Bookimed Expert Insight: South Korea is a global hub for cerebrovascular expertise. Gangnam Severance Hospital performs over 1,300 neurosurgeries annually. Doctors like Dr Han Yeongmin at NAEUN Hospital often bring insights from top US institutions. This high volume allows Korean teams to refine medication protocols. These protocols specifically support long-term bypass success.
Patient Consensus: Patients note that surgery is the main step in Korea. Still, daily low-dose aspirin and staying hydrated are vital lifelong habits. They often receive cholesterol or seizure medications temporarily for a smoother recovery after revascularisation.
South Korea provides screening for Moyamoya disease due to one of the highest global prevalence rates. Specialised centres use high-resolution MRI, digital subtraction angiography, and genetic RNF213 testing. Major Seoul facilities, such as JCI-accredited Severance Hospital, offer these diagnostic protocols. They help manage familial risks and adult haemorrhagic stroke.
Bookimed Expert Insight: South Korean neurosurgery hubs show immense specialisation. Centres like Gangnam Severance perform over 1,300 neurosurgical operations annually. Data shows specialists often hold dual international fellowships. For example, Dr Han Yeongmin trained at the Barrow Neurological Institute. This deep expertise means diagnostic accuracy is high for Moyamoya cases. Such cases may be misdiagnosed elsewhere as generic strokes.
Patient Consensus: Patients note that Moyamoya is difficult to spot without specific vascular imaging like MRA. They recommend that patients make sure their medical pathway includes both MRI and confirmatory catheter angiography in South Korea.